BiologicalActivity
Potentp21-activatedkinase(PAK)inhibitor(IC50valuesare14,33,39and575nMforPAK1,PAK2,PAK3andPAK4respectively).BlocksandreversestheDISC1knockdown-inducedreductionindendriticspinesizeincorticalneurons.AttenuatesdendriticspineeliminationandenhancesspinegenerationinDISC1knockdownmice.Amelioratesautism-likebehavioralsymptomsinfragileXmentalretardation1(Fmr1)knockoutmice.Brainpenetrantandorallybioavailable.
CompoundLibraries
FRAX486isalsoofferedaspartoftheTocriscreenPlusandTocriscreenKinaseInhibitorToolboxII.FindoutmoreaboutcompoundlibrariesavailablefromTocris.
TechnicalData
M.Wt | 513.39 |
Formula | C25H23Cl2FN6O |
Storage | Storeat-20°C |
Purity | ≥98%(HPLC) |
CASNumber | 1232030-35-1 |
PubChemID | 68060125 |
InChIKey | DHKFOIHIUYFSOF-UHFFFAOYSA-N |
Smiles | FC1=CC(NC3=NC(N(CC)C(C(C5=CC=C(Cl)C=C5Cl)=C4)=O)=C4C=N3)=CC=C1N2CCNCC2 |
Thetechnicaldataprovidedaboveisforguidanceonly.ForbatchspecificdatarefertotheCertificateofAnalysis.
AllTocrisproductsareintendedforlaboratoryresearchuseonly.
SolubilityData
Solvent | MaxConc.mg/mL | MaxConc.mM | |
---|---|---|---|
Solubility | |||
DMSO | 10.27 | 20 |
PreparingStockSolutions
Thefollowingdataisbasedontheproductmolecularweight513.39.Batchspecificmolecularweightsmayvaryfrombatchtobatchduetosolventofhydration,whichwillaffectthesolventvolumesrequiredtopreparestocksolutions.
Concentration/SolventVolume/Mass | 1mg | 5mg | 10mg |
---|---|---|---|
1mM | 1.95mL | 9.74mL | 19.48mL |
5mM | 0.39mL | 1.95mL | 3.9mL |
10mM | 0.19mL | 0.97mL | 1.95mL |
50mM | 0.04mL | 0.19mL | 0.39mL |